One of the defining characteristics of mature consumer markets is not simply the abundance of products, but the quality of consumer decision-making. Across sectors, rising financial awareness, easier access to information and digital discovery are changing what people choose to buy and how they
Imagine reaching retirement with a bond portfolio that works like a staircase. One bond matures this year, another next year, and another the year after, giving you access to money at different points instead of having to unlock the entire investment at once
Augmont Enterprises IPO Day 2: The initial public offering (IPO) of integrated gold and silver platform Augmont Enterprises Ltd is witnessing its second day of bidding today, August 24. So far, the public issue has been subscribed 2.88 times. The Rs 825-crore IPO
Gold prices remain high in India; check 22K, 24K rates in Mumbai, Delhi, Bengaluru International gold prices also climbed to a more than three-month high on Monday. Published on: Aug 24, 2026, 13:46:24 IST By HT News Desk Prefer HTon Google Share via Copy link Gold prices remained high in India on
Nearly three-fourth of large-cap active funds underperformed a blended (LargeMidCap) benchmark over a 10-year period, according to the 2025 report by SPIVA (S&P Indices Versus Active). In this article, we discuss two reasons that could, perhaps
Indian Stock Market Today, August 24: The domestic equity markets opened higher on Monday, but gains remained measured as investors continued to track elevated crude oil prices and geopolitical tensions in West Asia. At 9:16 am, the BSE Sensex was up 205 points, or 0.26%, at 77,746.06
Businesses from India and the U.S. have expressed interest in investing in Bangladesh and made proposals to improve the country's investment climate, Commerce Minister Khandakar Abdul Muktadir has said. Mr. Muktadir’s remarks on Saturday (August 22
Minimalistic retractable door handles became a signature feature of electric vehicles (EVs), but the controversial designs are now at the centre of China's biggest car recall, affecting more than 4 million vehicles. The recall, which includes 2.98 million Chinese-made Teslas
India's cheap weight-loss drugs could reshape global obesity fight
India could soon get a lot thinner - at least in theory.
On Friday the patent on semaglutide - the molecule behind Danish drugmaker Novo Nordisk's blockbuster weight-loss drugs Wegovy and Ozempic - expires in the country.
This will allow domestic pharmaceutical companies to release cheaper copies or generics, triggering a rush of competition that could slash prices by more than half and rapidly expand access for people in India, and eventually in other countries too.
Investment bank Jefferies has called it a potential "magic-pill moment" for India, predicting the semaglutide market could eventually reach $1bn domestically with the right pricing and uptake.
Analysts expect around 50 branded semaglutide generics to enter the market within months - a familiar pattern in India's fiercely competitive pharmaceutical industry. When the diabetes drug sitagliptin went off patent in 2022, about 30 branded versions appeared within a month and nearly 100 within a year.
India's pharmaceutical industry, currently worth about $60bn, is expected to double by 2030. Much of it is built on generics - a manufacturing muscle that now sets the stage for fierce competition over semaglutide. What has until now been an expensive injection largely confined to affluent patients could soon become far more common.
Originally developed to treat diabetes, these drugs are now being hailed as game changers for weight loss, offering results that few previous treatments could match. Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists, which mimic a hormone that regulates appetite and blood sugar.
By boosting insulin release and slowing the emptying of the stomach, the drugs make people feel full sooner and stay full longer. Originally developed for diabetes, they have become some of the most sought-after weight-loss treatments in the world.
Several Indian drugmakers are already preparing to make the move. According to Sheetal Sapale, vice-president at research firm Pharmarack, major firms including Cipla, Sun Pharma, Dr Reddy's Laboratories, Biocon, Natco, Zydus and Mankind Pharma are readying branded generics, with many more likely to follow. Prices are expected to fall sharply.
Current monthly treatment costs are steep: Ozempic typically sells for 8,800 - 11,000 rupees ($95-$119; £71-£89), while Wegovy can cost 10,000-16,000 rupees ($108-$173). Sapale expects generic competition to push that down to roughly 3,000-5,000 rupees ($36-54) per month.
Lower prices could transform the market.
India's anti-obesity drug sector - covering both injectables and oral medicines - has already grown rapidly, from roughly $16m in 2021 to close to $100m, according to Pharmarack. Demand accelerated after the launch of Rybelsus in 2022, the first oral version of semaglutide.
The surge reflects a broader health shift.
India already has more than 77 million people with type-2 diabetes and one of the world's largest populations of overweight adults. Urban lifestyles, carbohydrate-heavy diets and sedentary habits have helped drive both conditions.
For doctors, cheaper GLP-1 drugs could soon add a powerful new tool to treat them.
Weight-loss drugs are also moving beyond endocrinology clinics. Cardiologists use them to help patients shed weight before procedures such as angioplasty, orthopaedic surgeons to ease stress on joints before knee surgery, and chest physicians to treat conditions such as obstructive sleep apnoea.
Muffazal Lakdawala, a Mumbai-based bariatric surgeon, says these drugs could dramatically expand treatment for India's large population of patients with diabetes and obesity.
Until recently, he notes, access was limited: injectable GLP-1 drugs were expensive and difficult to obtain, while the oral drug Rybelsus was the only widely available option.
"It is great that these will become cheaper so that more of the diabetic and obese Indian population can access them," he says.
But he adds a warning: "The quality of the drugs being made here must be very tightly regulated."
That caution reflects a broader reality about India's pharmaceutical industry - the global powerhouse behind low-cost generic medicines.
The country is the world's largest supplier of generic medicines, producing roughly 60,000 brands across more than 60 therapeutic categories and accounting for around 20% of global generic supply.
Its reputation as the "pharmacy of the world" rests largely on its ability to turn expensive medicines into affordable mass-market products.
The most celebrated example came two decades ago, when Indian firms helped slash the price of HIV antiretroviral drugs, dramatically expanding treatment across Africa and the developing world.
Today India supplies medicines to over 200 countries, meeting more than half of Africa's generic drug demand, about 40% of generics used in the US, and roughly a quarter of medicines in the UK.
The export potential of Indian generic weight-loss drugs is humongous," says Namit Joshi, chairman of the government's Pharmaceuticals Export Promotion Council of India. "The US market alone could scale to $10bn within a few years as obesity rates drive demand.
That would be a sizeable addition to India's pharmaceutical trade: the country's generic drug exports currently total $30.46bn, with the US already its largest market.
Yet enthusiasm among doctors remains tempered by caution.
GLP-1 drugs are powerful but not risk-free. Side-effects can include nausea, vomiting and digestive problems; rarer complications include gallstones or pancreatitis. Rapid weight loss without adequate protein intake or exercise can also lead to muscle loss.
Doctors say many patients misunderstand the role of the drugs. Some expect dramatic weight loss within weeks, influenced by social-media hype and celebrity endorsements.
Mumbai-based diabetologist Rahul Baxi says success depends not just on the drug but on "right patient selection".
Doctors look beyond Body Mass Index (BMI) - a basic measure of weight relative to height - to related conditions such as diabetes or high cholesterol. Lifestyle matters too: if a patient's diet remains unhealthy, the drug alone may not be enough.
Patients often arrive seeking a quick fix. "People come asking to lose 10kg in three months," Baxi says.
Rapid weight loss can have downsides. Too fast, and patients may lose fat from the face, neck, arms and thighs, leaving them looking frail.
"Gradual weight loss, slow dose escalation, and a focus on protein intake, exercise and strength training are key to healthier outcomes," says Baxi.
Another challenge is that weight loss often reverses once the drugs stop. Appetite can rebound strongly as the body resists losing fat.
"If you stop the drugs, the appetite comes back voraciously," Baxi says.
There are also concerns about misuse as prices fall.
Physicians report patients being prescribed high doses by gym trainers, beauty clinics or dieticians with no authority to do so. Online pharmacies sometimes dispense the drugs after cursory consultations. Beauticians already advertise rapid slimming "packages" for weddings or social events.
Such practices could spread as cheaper generics become more widely available.
More access to cheap drugs means a higher chance of abuse," says Bhaumik Kamdar, a Mumbai-based chest physician. "Access calls for more responsibility - and stricter regulation. I am cautiously optimistic about these drugs.
That warning echoes Lakdawala's concerns about manufacturing standards.
These are very beneficial drugs," he says. "We don't want side effects arising from poor-quality medicines and giving the molecule itself a bad name.
The government is also trying to temper the hype. In an advisory last week, India's drug regulator warned pharmaceutical companies against promoting prescription weight-loss medicines such as GLP-1 drugs directly to consumers.
Advertising that promises dramatic results or downplays the need for diet and exercise could be deemed misleading, officials said, stressing that such medicines should only be used under medical supervision.
For regulators and doctors alike, the coming months may therefore test whether India can balance affordability with oversight.
Baxi says he asks patients to improve their lifestyle and diet before prescribing weight-loss drugs.
Even then, they are first put on a higher-protein diet with a dietician's help, he says. Current evidence suggests the drugs may need to be taken over a long term. But many patients arrive asking for a "quick fix after seeing Instagram reels", putting pressure on doctors.
Yet, the rewards could be significant. A medicine that once cost tens of thousands of rupees a month could become accessible to millions - and perhaps eventually to patients far beyond India.
"I am actually writing on prescriptions to many patients: Come to me after 20 March when the prices come down," says Baxi.
Source: BBC
Related Posts: Business
Tempsens Instruments India IPO Day 3: The initial public offering (IPO) of temperature sensing and heating solutions provider Tempsens Instruments Ltd is witnessing its final day of bidding today, August 24. So far, the public issue has been subscribed by a strong 31.34 times. The Rs 650-crore IPO
11 hours ago
S&P 500 just hit a level seen only once before in 155 years — could a market crash be next? The S&P 500 CAPE ratio hit 40 for only the second time in 155 years, raising concerns about valuations, future returns and a possible market correction. Updated on: Aug 23, 2026
14 hours ago
Anthropic $2 trillion IPO: Why investors think it could be worth more than SpaceX Anthropic could reach a $2 trillion IPO valuation as revenue surges, raising questions about whether the AI company can be worth more than SpaceX. Published on: Aug 23, 2026
14 hours ago
US President Donald Trump has said Canada wants "the benefits of being a State, without being one" after trade talks between the two countries collapsed late on Friday. In his first comments since negotiations broke down, triggering new 50% US tariffs on a range of Canadian goods
1 days ago
India’s payments sector has raised $5.8 billion across 371 equity funding rounds since January 2021, while producing eight initial public offerings (IPOs) and triggering 25 acquisitions, as the industry increasingly consolidates around a handful of well-funded players
1 days ago
Can Reddit survive in the AI era? It wants more cash for its data—and more of people’s time Published on: Aug 22, 2026, 16:40:48 IST The Economist Prefer HTon Google Share via Copy link Earlier this summer “Backrooms”, a horror flick, became one of the most successful independent films ever
1 days ago
What with a 250th birthday, Taylor Swift's wedding and the football World Cup, Americans could be forgiven for taking their eye off the ball this summer. But signs of economic trouble have been building. This week they hit the headlines when US national debt passed the $40tn (£29.4tn) mark
1 days ago
Insurance regulator IRDAI has directed Edelweiss Life Insurance and Pramerica Life Insurance, in separate orders on August 20, not to open new place of business for six months for non-compliance with Expenses of Management (EoM) limits in 2024-25
2 days ago
India remains a very attractive destination for global investments and its economic fundamentals form the basis for strong investor confidence, Jyoti Jeetun, the Minister of Financial Services and Economic Planning of Mauritius told The Hindu in an interview
2 days ago
A fresh wave of US tariffs on a wide array of Canadian goods has come into effect as of midnight on Saturday after a last minute break down in trade talks. Announcing the suspension of negotiations shortly before the Friday night deadline, Canadian Prime Minister Mark Carney said he would impose
2 days ago
TCS Employee Surveillance Row: Tata Consultancy Services (TCS), India’s largest IT services company, on Friday denied reports that it is using monitoring tools to track individual employee activity on company-issued laptops. The IT giant said the purpose of the tools is to monitor the overall
2 days ago
Walmart stock falls 9% as retailer finally brings Apple Pay, Google Pay Walmart stock fell 9% after earnings despite beating estimates and raising guidance. The retailer will add Apple Pay and Google Pay Tap to Pay from August 24. Updated on: Aug 21, 2026
2 days ago
TikTok has agreed to pay $400m (£293m) to the US to end a lawsuit alleging its platform violated children‘s privacy, marking one of the largest ever settlements over the issue. The deal stems from a 2024 suit by the Department of Justice under former President Joe Biden alleging TikTok and its
2 days ago
What’s next for Nvidia after the AI chip boom? Wall Street wants more—here’s what investors need to know Nvidia stock faces high expectations ahead of August 26 earnings as Wall Street watches AI growth, valuation, open-source models and Nvidia's next big story. Updated on: Aug 22, 2026
2 days ago
Costco dividend rises: Why a $10,000 investment pays only $61 yearly A $10,000 Costco investment earns only about $61 a year in regular dividends. Here’s why investors still buy COST for growth and special dividends. Updated on: Aug 20, 2026
3 days ago
Leaving education, getting a job, buying a home and perhaps starting a family: the path previous generations followed may seem a distant dream to many now. But is it getting a bit easier - at least when it comes to getting on the housing ladder? Today's prospective first-time buyers may well feel
3 days ago
Nearly six months after US President Donald Trump vowed a swift victory over Iran, the conflict appears to be at a standstill, with prospects of a military victory or negotiated settlement growing dimmer. To break the deadlock, Trump has vowed an "economic D-Day" under which any country that does
3 days ago
Why US stocks fell today: Dow, S&P 500, Nasdaq drop as oil and bond yields rise US stocks fell as oil prices and Treasury yields rose. Dow, S&P 500 and Nasdaq dropped as Trump's Iran threat, Walmart and the bond market hit Wall Street. Published on: Aug 20, 2026
3 days ago
Crypto stocks surge as Trump backs Clarity Act: Coinbase, Circle, miners rise Crypto stocks surge as Trump backs the Clarity Act. Coinbase, Circle, Bitcoin miners and other crypto shares rise as investors expect clearer US crypto rules. Updated on: Aug 20, 2026
4 days ago
Stock Market Today, August 20: The domestic equity market snapped its seven-day losing streak and ended sharply higher on Thursday, August 20, as broad-based buying lifted sentiment across sectors after the US Treasury stepped in to contain the surge in global bond yields
4 days ago
The Reserve Bank of India RBI has accorded its approval to Life Insurance Corporation of India (LIC) for acquiring an aggregate holding of up to 9.99% of the paid-up share capital or voting rights in HDFC Bank Ltd., the bank said in a filing with the exchanges on Wednesday (August 19, 2026) night
4 days ago
Customers have shared their outrage after an app used by many businesses to track timesheets and produce invoices hiked bills by as much as 1500%, with one person calling it "daylight robbery". Richard Haldenby, head of UK consultancy firm Salentis
4 days ago
Bitcoin Price Today, August 20: Bitcoin surged to the $70,000 mark on Thursday, recording one of its sharpest gains in recent months as a combination of lower US Treasury yields, a weaker dollar, strong institutional demand and large-scale short liquidations pushed the broader cryptocurrency market
4 days ago
US President Donald Trump has said he will launch tougher economic measures against Iran, as well as any country and that helps or does business with the country. He wrote in all capital letters on Truth Social that he was launching "the most crushing economic operation ever taken against any
4 days ago
The domestic equity markets were trading firmly higher on Thursday, August 20, with buying visible across large-cap, mid-cap and small-cap stocks. The gains strengthened through the session, with the benchmark Sensex rising more than 600 points by 1:20 pm
4 days ago
U.S. President Donald Trump will host cryptocurrency executives at the White House on Wednesday as U.S. financial regulators this week prepare to advance their framework for certain digital assets. Trump, who has earned more than $1.4 billion from his family’s crypto ventures
4 days ago
Telecom inflation, chargers and the number 45, and Small Talk ASL app Beyond the regular noise, a closer look at personal technology. 20 August 2026. Published on: Aug 20, 2026, 08:00:58 IST By Vishal Mathur Prefer HTon Google Share via Copy link Opening thoughts. Josh Staub
4 days ago
